Computational Biology & Digital Sciences
At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
Search
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Oncology Translational Science
Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Science Focus
Our Science Focus at Boehringer Ingelheim
Research Beyond Borders
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Data Privacy
Data protection In an increasingly digitalized world, the effective protection of personal data and the privacy of each individual plays an increasingly important role. For this reason, on May 25, 2018, the new EU General Data Protection Regulation GDPR
Fostering Science
Fostering Science
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Science Stories
Science Stories
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
“My ultimate goal is to cure cancer”
“My ultimate goal is to cure cancer”
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
Grass Roots
Grass Roots
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Animal Health Partnering Interests
Animal Health Partnering Interests
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Parasiticides
Parasiticides